Trial Profile
Tolerability and Immunogenicity Study of FLUVAL AB Influenza Vaccine (trivalent, seasonal, active ingredient content: 15 μgHA/strain/0.5 mL) for the Use in the Season 2013/2014 in Adults and Elderly Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Omninvest
- 04 Sep 2013 New trial record